Overview
Neutrophilic Leukemia (NEH), also known as Neutrophilic Umbilical Cord Blood Syndrome or Neutrophilic Dermatosis, is a rare hematologic disorder characterized by an abnormal proliferation of mature neutrophils in the peripheral blood and tissues. This condition can present with diverse clinical manifestations, often complicating its diagnosis and management. The epidemiology, clinical presentation, diagnostic approach, and treatment strategies vary significantly between pediatric and adult populations. Understanding these nuances is crucial for effective patient care. In adults, NEH frequently occurs in the context of underlying malignancies, particularly those treated with chemotherapy, whereas pediatric cases are more commonly associated with physical stressors like strenuous activity. The clinical spectrum ranges from cutaneous manifestations to systemic inflammatory symptoms, necessitating a comprehensive evaluation and tailored therapeutic interventions.
Epidemiology
NEH exhibits distinct epidemiological patterns between adult and pediatric populations. Among a cohort of 47 patients studied, 76% of adult cases were linked to underlying malignancies, often managed with chemotherapy regimens, highlighting the potential role of immunosuppressive states in disease pathogenesis [PMID:37350432]. This association underscores the importance of considering NEH in oncology settings, particularly when patients present with unexplained neutrophilia and dermatological symptoms. In contrast, pediatric patients showed a markedly different profile, with only 8% having a concurrent malignancy. Instead, 83% of pediatric cases were triggered by physical stressors such as vigorous exercise, suggesting a possible link between physical exertion and the onset of NEH in children [PMID:37350432]. These findings indicate that clinicians should consider both the patient's medical history and recent activities when evaluating NEH, tailoring their approach based on age-specific risk factors.
Clinical Presentation
The clinical presentation of NEH varies but often includes characteristic cutaneous manifestations that can guide early suspicion and diagnosis. Both adult and pediatric patients frequently present with palmoplantar eruptions, which are erythematous, often painful lesions typically affecting the palms and soles [PMID:37350432]. These eruptions are a hallmark of NEH and can significantly impact quality of life due to their pruritic nature and functional limitations. Beyond cutaneous symptoms, systemic involvement is not uncommon. Two reported cases highlighted the presence of urticaria accompanied by systemic inflammatory symptoms such as night sweats, fevers, and polyarticular arthritis [PMID:23715523]. These systemic manifestations suggest an underlying inflammatory process that extends beyond the skin, potentially involving multiple organ systems. Recognizing these varied presentations is crucial for timely intervention and appropriate management.
Diagnosis
Diagnosing NEH requires a multifaceted approach, integrating clinical suspicion with laboratory and histopathological findings. Histological examination remains pivotal, especially in adult patients, where definitive diagnosis often hinges on the identification of neutrophilic infiltration in affected tissues [PMID:37350432]. However, the necessity for biopsy in pediatric cases appears less stringent, as clinical features alone can sometimes suffice for diagnosis, reflecting a more conservative diagnostic strategy in younger patients [PMID:37350432]. In clinical practice, the presence of unexplained neutrophilia coupled with characteristic skin lesions should prompt consideration of NEH. Additionally, when urticaria persists despite standard antihistamine therapy and is accompanied by systemic inflammatory signs, clinicians should broaden their differential to include Neutrophil-Associated Skin Infiltration (NUSI), as highlighted in a case series [PMID:23715523]. This approach ensures that NEH is not overlooked in patients presenting with atypical urticarial reactions.
Differential Diagnosis
Differentiating NEH from other neutrophilic dermatoses and systemic inflammatory conditions is essential for accurate diagnosis and management. Conditions such as Sweet's syndrome, pyoderma gangrenosum, and drug reactions can present with similar cutaneous manifestations, necessitating careful clinical evaluation and laboratory testing [PMID:37350432]. In adults, the presence of underlying malignancy or recent chemotherapy can further complicate the differential, as these factors can induce similar neutrophilic responses. For pediatric patients, physical triggers like infections or strenuous activities should be considered alongside NEH, as these can also lead to neutrophilic dermatoses [PMID:37350432]. Biopsy findings, particularly the characteristic neutrophilic infiltration, are crucial for distinguishing NEH from other neutrophilic disorders, although pediatric cases may sometimes be diagnosed clinically without the need for invasive procedures. This highlights the importance of a tailored diagnostic approach based on patient age and clinical context.
Management
The management of NEH varies based on the underlying etiology and clinical presentation, with significant differences noted between idiopathic and malignancy-associated cases. In adults, idiopathic NEH tends to have higher recurrence rates compared to cases associated with malignancy, suggesting that the presence of an underlying condition might influence disease course and response to therapy [PMID:37350432]. Conventional treatments, including corticosteroids, antihistamines, and immunosuppressants, are often the initial therapeutic approach but may not always achieve satisfactory outcomes. For refractory cases, targeted therapies have shown promise. Both reported cases of systemic involvement responded dramatically to anakinra, an interleukin-1 receptor antagonist, after conventional treatments failed [PMID:23715523]. This underscores the potential benefits of biologic agents targeting specific inflammatory pathways in managing severe or refractory NEH. In pediatric patients, management strategies might be less aggressive, focusing initially on supportive care and addressing any triggering factors, though specific pediatric treatment guidelines remain limited.
Complications
NEH can lead to a range of complications that extend beyond the primary cutaneous manifestations, impacting multiple organ systems. Polyarticular arthritis is a notable systemic complication, often requiring rheumatologic intervention to manage joint pain and inflammation [PMID:23715523]. Additionally, gastrointestinal symptoms, such as those experienced by one patient on colchicine therapy, highlight the potential for drug-related side effects that can complicate treatment [PMID:23715523]. These complications necessitate a multidisciplinary approach to care, involving dermatologists, rheumatologists, and gastroenterologists, depending on the clinical presentation. Monitoring for these systemic effects is crucial for optimizing patient outcomes and adjusting therapeutic strategies as needed.
Prognosis & Follow-up
The prognosis of NEH varies significantly between idiopathic and malignancy-associated cases, influencing long-term management and follow-up requirements. Idiopathic NEH in adults is often characterized by a more recurrent course, necessitating vigilant monitoring and prompt intervention upon symptom recurrence [PMID:37350432]. In contrast, cases linked to malignancy may show more stable outcomes once the underlying condition is managed effectively. The successful use of anakinra in achieving complete symptom control in reported cases suggests a favorable prognosis with targeted biologic therapy [PMID:23715523]. Regular follow-up is essential to detect early signs of recurrence or new complications, particularly in adults with idiopathic NEH. Clinicians should maintain a high index of suspicion for relapse and be prepared to adjust treatment plans accordingly, ensuring sustained remission and optimal quality of life for patients.
References
1 Isaq NA, Anand N, Camilleri MJ, Mohandesi NA, Alavi A. Neutrophilic eccrine hidradenitis: a retrospective study. International journal of dermatology 2023. link 2 Belani H, Gensler L, Bajpai U, Meinhardt E, Graf J, Pincus L et al.. Neutrophilic urticaria with systemic inflammation: a case series. JAMA dermatology 2013. link
2 papers cited of 3 indexed.